» Articles » PMID: 35053810

A Comparison of IgG Index and Oligoclonal Band in the Cerebrospinal Fluid for Differentiating Between RRMS and NMOSD

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Jan 21
PMID 35053810
Authors
Affiliations
Soon will be listed here.
Abstract

As the oligoclonal band in the cerebrospinal fluid (CSF-OCB) in predicting relapsing-remitting multiple sclerosis (RRMS) is less sensitive in Asian populations than that in westerners, it remains elusive whether the IgG index could serve as an alternative. The purpose of this study was to compare these two methods of differentiating between RRMS and neuromyelitis optica spectrum disorder (NMOSD) in Chinese patients. A total of 171 patients (81 RRMS and 90 NMOSD) were retrospectively recruited, of whom 82 (56 RRMS and 26 NMOSD) received the CSF-OCB testing additionally. When the onset age was ≤38.5 years, IgG index with the threshold of 0.67 had a significant agreement (k = 0.4, < 0.001) with the diagnosis while CSF-OCB failed to discriminate (k = 0.1, = 0.578). However, when the onset age was >38.5 years, both IgG index with the threshold of 0.8 and CSF-OCB were moderately consistent with the diagnosis (both k > 0.4, < 0.05). In total, our optimized algorithm had the sensitivity, specificity, and predictive accuracy of 0.778, slightly outperforming the CSF-OCB model. Accordingly, a combination of the onset age and IgG index could serve as an alternative to CSF-OCB for differentiating between RRMS and NMOSD in Chinese patients.

Citing Articles

Evaluation of Brain and Spinal Cord Lesions and Cerebrospinal Fluid Analysis in Detecting Demyelinating Diseases in Patients with Optic Neuritis.

Mori S, Chihara N, Iwaki Y, Okuda-Arai M, Takano F, Ueda K Neuroophthalmology. 2025; 49(2):154-160.

PMID: 40051714 PMC: 11881855. DOI: 10.1080/01658107.2024.2419846.


Application of oligoclonal bands and other cerebrospinal fluid variables in multiple sclerosis and other neuroimmunological diseases: a narrative review.

Jin H, Lu Q, Gao F, Hao H Ann Transl Med. 2023; 11(7):282.

PMID: 37090049 PMC: 10116428. DOI: 10.21037/atm-21-3073.

References
1.
Simonsen C, Flemmen H, Lauritzen T, Berg-Hansen P, Moen S, Celius E . The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. Mult Scler J Exp Transl Clin. 2020; 6(1):2055217319901291. PMC: 6977237. DOI: 10.1177/2055217319901291. View

2.
Roemer S, Parisi J, Lennon V, Benarroch E, Lassmann H, Bruck W . Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007; 130(Pt 5):1194-205. DOI: 10.1093/brain/awl371. View

3.
Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S . Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007; 130(Pt 5):1224-34. DOI: 10.1093/brain/awm047. View

4.
Mao-Draayer Y, Thiel S, Mills E, Chitnis T, Fabian M, Sand I . Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations. Nat Rev Neurol. 2020; 16(3):154-170. DOI: 10.1038/s41582-020-0313-y. View

5.
Salzer J, Svenningsson R, Alping P, Novakova L, Bjorck A, Fink K . Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy. Neurology. 2016; 87(20):2074-2081. PMC: 5109942. DOI: 10.1212/WNL.0000000000003331. View